CAM
AMAG

ClariVest Asset Management’s AMAG Pharmaceuticals AMAG Stock Holding History

ClariVest Asset Management’s Portfolio AMAG Stock Details AMAG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-118,276
Closed -$1.18M – 779
2019
Q2 		$1.18M Sell
118,276
-36,500
-24% -$394K 0.03% 295
2019
Q1 		$1.99M Buy
154,776
+55,892
+57% +$832K 0.04% 314
2018
Q4 		$1.5M Buy
98,884
+24,888
+34% +$474K 0.03% 344
2018
Q3 		$1.48M Sell
73,996
-3,334
-4% -$75.9K 0.03% 369
2018
Q2 		$1.51M Sell
77,330
-1,311
-2% -$29K 0.03% 381
2018
Q1 		$1.58M Buy
+78,641
New +$1.33M 0.03% 366
2017
Q4 		– Sell
-38,100
Closed -$703K – 793
2017
Q3 		$703K Buy
38,100
+900
+2% +$16.8K 0.02% 362
2017
Q2 		$685K Buy
37,200
+400
+1% +$7.93K 0.02% 367
2017
Q1 		$830K Buy
36,800
+7,100
+24% +$170K 0.02% 354
2016
Q4 		$1.03M Buy
+29,700
New +$887K 0.03% 334
2016
Q2 		– Sell
-18,670
Closed -$437K – 711
2016
Q1 		$437K Sell
18,670
-20,529
-52% -$487K 0.01% 369
2015
Q4 		$1.18M Sell
39,199
-1,994
-5% -$64.4K 0.03% 272
2015
Q3 		$1.64M Sell
41,193
-850
-2% -$52.8K 0.05% 210
2015
Q2 		$2.9M Buy
42,043
+28,943
+221% +$1.82M 0.09% 159
2015
Q1 		$716K Sell
13,100
-16,092
-55% -$767K 0.02% 315
2014
Q4 		$1.24M Buy
+29,192
New +$1.05M 0.04% 208
2014
Q2 		– Sell
-75,323
Closed -$1.46M – 645
2014
Q1 		$1.46M Buy
75,323
+15,513
+26% +$330K 0.06% 195
2013
Q4 		$1.45M Sell
59,810
-600
-1% -$14.1K 0.06% 188
2013
Q3 		$1.3M Sell
60,410
-8,236
-12% -$195K 0.06% 193
2013
Q2 		$1.53M Buy
+68,646
New +$1.51M 0.07% 185

Other funds holding AMAG

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

ClariVest Asset Management's AMAG Position: Q3 2019 in Review

ClariVest Asset Management sold out of AMAG Pharmaceuticals (AMAG) in Q3 2019, closing a stake of 118,276 shares — an estimated $1.18M sold.

ClariVest Asset Management first reported a position in AMAG in Q2 2013 and held it in 20 quarters. The position peaked at $2.9M in Q2 2015. 156 funds tracked by Wall St. Rank hold AMAG as of Q3 2019.

  • ClariVest Asset Management reported no remaining AMAG Pharmaceuticals position as of Q3 2019 after selling out during the quarter.
  • ClariVest Asset Management sold 118,276 AMAG Pharmaceuticals shares in Q3 2019, an estimated $1.18M.
  • ClariVest Asset Management first reported a position in AMAG Pharmaceuticals in Q2 2013 and held it in 20 quarters.
  • ClariVest Asset Management's AMAG Pharmaceuticals position peaked at $2.9M in Q2 2015.
  • 156 funds tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q3 2019.

Based on ClariVest Asset Management's 13F filing for Q3 2019, filed 12 Nov 2019.